The loneliest number: The Tipline for 8 December 2021
Martin Shrekli is on his own. Two of his fellow defendants – his former company and his former partner – have settled allegations that they illegally delayed generic competition for the life-saving drug Daraprim. Shkreli is not attending next week’s trial but, as per usual, “Pharma Bro” will be the centre of attention.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10